OVERVIEW

Scientific Updates on Antiplatelet Therapies for the Management of Patients with Acute Coronary Syndrome is organized by the AcademicCME.

Program Dates: January 23, 2020 - January 22, 2021

Accreditation:
Credit Designation Statements
• AcademicCME designates this live material for a maximum of 1.50 AMA PRA Category 1 Credits™.
• AcademicCME designates this live material for a maximum of 1.50 CNE Contact Hours, including 1.50 pharmacotherapeutic contact hours (Provider number P0491).
• AcademicCME designates this continuing education activity for 1.50 CPE Contact Hours (0.15 CEUs) of continuing pharmacy education credit

Program Overview:
This continuing education activity is derived from content presented at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada. The program will highlight recent advances in antiplatelet therapeutics for acute coronary syndrome. The expert faculty will analyze current guidelines and provide insight into best approaches for developing effective patient-specific treatment plans that include the clinical pharmacy team. Navigating combination therapies while optimizing duration of antiplatelet therapies in the ACS patient will be reviewed in an interactive panel format. The faculty will also discuss the role of the pharmacist in the cardiac catheterization laboratory, covering procedural best practices, medication reconciliation, and patient education. This activity will provide learners with a better understanding of acute coronary syndrome and the central role of platelet inhibition during early management, particularly in the catherization lab, to improve treatment and management in their pharmacy practice.

Learning Objectives:
• Review current guidelines for antiplatelet therapies for ACS to develop the most effective patient-specific treatment plans
• Analyze the latest clinical trial data of antiplatelet agents for the treatment of patients with ACS
• Identify an optimal pharmacist role in the cardiac catheterization laboratory